Sentences with phrase «most ovarian»

Most ovarian tumors are age dependent so an older animal has more risk of developing tumors.

-- Ovarian Cysts Most ovarian cysts are asymptomatic and normally resolve on their own.

Most ovarian cancers are serous carcinomas, which develop in the tissue lining the ovaries and are subtyped into high - grade and low - grade.

Do most ovarian tumors harbor this defect?

«If studies in larger groups of women confirm our finding that the fallopian tubes are the site of origin of most ovarian cancer, then this could result in a major change in the way we manage this disease for patients at risk.»

Not exact matches

«Color's $ 99 BRCA Test, the most affordable genetic test for BRCA1 and BRCA2 ever on the market, is now available to any woman who wants to take the first step toward learning her risk for hereditary breast and ovarian cancer,» said the company in a blog post.

Most women don't understand that the incidence of endocrine disruptive disorders such as endometriosis, fibroids, polycystic ovarian syndrome, infertility, early onset puberty, early onset menopause, heavy, painful and prolonged periods and breast cancer are mainly caused by the endocrine disruptive chemicals found in skin, hair, beauty and personal products.

Join us in this episode as we learn more about PCOS (polycystic ovarian syndrome), one of the most prevalent hormonal imbalances and top cause of infertility and subfertility in women.

The most notable effect of ovarian stimulation is multiple pregnancies.

The most important measure of fertility as women age is ovarian reserve, or the egg supply in the ovaries.

This decline in ovarian reserve is one of the most important issues of age and infertility.

A large number of ovaries increases the chance of pregnancy, but unfortunately has also been associated with ovarian hyperstimulation syndrome (OHSS), which is sometimes called the most important side effect of fertility treatment.

The most common fertility drug risks are conceiving a multiple pregnancy (like twins or triplets or more) and developing ovarian hyperstimulation syndrome (OHSS).

The most common type of ovarian cyst is called a functional cyst.

The most well - known are breast cancer gene 1 (BRCA1) and breast cancer gene 2 (BRCA2), both of which significantly increase the risk of both breast and ovarian cancer.

Paclitaxel and another chemotherapy drug, carboplatin, are considered standard, first - line treatments for advanced ovarian cancer, experts say, and most patients respond to the drugs initially.

Many doctors who no longer advise mammograms for most women younger than 50 continue to suggest them for those with a family history of breast or ovarian cancer.

According to a 2014 review of cancer medicines from the World Health Organization, EOC is the most common type of ovarian cancer and has a 5 - year survival rate of approximately 40 %.

In an earlier Penn Medicine study, 38 percent of all patients (and 46 percent of females with the condition) were found to have a tumor, most commonly it was an ovarian tumor.

«Because there is currently no reliable screening available for ovarian cancer, most cases are diagnosed at advanced stages,» said the study's author, Bo (Bonnie) Qin, PhD, a postdoctoral associate at Rutgers Cancer Institute of New Jersey.

Doctors have had little success diagnosing ovarian cancer at its earliest, most treatable states or identifying women at risk for the disease, for example.

Today, a team of researchers at Cold Spring Harbor Laboratory reports in the journal Genes & Development that they have arrived at «new insights into signaling events that underlie metastasis in ovarian cancer cells,» says Gaofeng Fan, Ph.D., postdoctoral investigator who conducted most of the experiments, in the laboratory of his mentor, CSHL Professor Nicholas K. Tonks.

The discovery of 6 - OH - dopa has therapeutic implications for more than just breast and ovarian cancer — the diseases most widely associated with BRCA mutations.

Diamond is also quick to point out that while the current study shows that COXEN could have been used to predict the most useful drug in many of these cases of advanced ovarian cancer, the actual use of the model will be possible only after validation with a prospective clinical trial.

Importantly, elevated BRCA1 methylation was confined to patients diagnosed with so - called high - grade serous tumors, the most aggressive variant of ovarian cancer, which also is the variant associated with BRCA1 mutations.

Of the 122 such ovarian malignancies, most showed up around 6 years into a study.

This included glioblastoma, the most aggressive of brain tumours, as well as lung, prostate, ovarian, breast, pancreatic and skin cancer.

Because most women received high doses, the researchers could not determine if the dosage affected the ovarian reserve.

Interestingly, cisplatin - resistant epithelial ovarian cancer cells were most sensitive to indomethacin.

This analysis led to the identification of several lncRNAs that are overexpressed in a particular subset of ovarian cancer, those that are thought to be the most aggressive.

«For decades, women have been treated with a combination of treatment options, resulting in poor prognosis for most women with advanced - stage ovarian cancer, but there are many survivors as well,» said Dr. Narod, senior scientist at Women's College Research Institute.

This suggests that targeting the CA125 - negative cells may improve outcomes in these high - grade serous cancers, the most common subtype of ovarian cancer, said Memarzadeh, who also is a UCLA associate professor of obstetrics and gynecology and director of the G.O. Discovery Lab.

Ovarian cancer researchers have identified a protein biomarker expressed on the surface of tumour cells in high - grade serous ovarian cancer, the most common and lethal subtype of the dOvarian cancer researchers have identified a protein biomarker expressed on the surface of tumour cells in high - grade serous ovarian cancer, the most common and lethal subtype of the dovarian cancer, the most common and lethal subtype of the disease.

«Combination therapy may be more effective against the most common ovarian cancer.»

«Most women whose ovarian cancer is recurring want every edge to extend their lives,» said lead author Robert L. Coleman, MD, of The University of Texas MD Anderson Cancer Center in Houston.

Therefore, ovarian cancer is highly lethal because most women have advanced disease when they are diagnosed.

Mutations in the BRCA1 gene are one of the most common risk factors for breast and ovarian cancers.

Some scientists have suspected that the most common form of ovarian cancer may originate in the fallopian tubes, the thin fibrous tunnels that connect the ovaries to the uterus.

Tamara Minko, professor in the Ernest Mario School of Pharmacy, and Lorna Rodriguez, professor of obstetrics, gynecology and reproductive sciences at Robert Wood Johnson Medical School, say because there is not a good screening method for ovarian cancer, most women with the disease are not diagnosed until after it has metastasized to other organs and surgery and chemotherapy are not as effective.

«This aligns with what we see in the clinic, that newly - diagnosed ovarian cancer patients most often already have widespread disease,» says Velculescu.

Scientists at Rutgers University have developed a targeted drug delivery system that they believe could make ovarian cancer more treatable and increase survival rates for the most deadly gynecological cancer in the United States.

And she's more familiar than most with the panels: Her mother, my nonbiological aunt, is fighting ovarian cancer and signed up for a panel of 41 genes offered by the University of Washington, Seattle.

Indeed, some of the most interesting papers presented at the conference, which brought about 20,000 scientists to San Francisco last week, described innovative new polymers, the generic chemical term, that could help thwart ovarian cancer and infections, and regenerate damaged nerves.

Ovarian cancer is the fifth leading cause of cancer death in women, the leading cause of death from gynecologic malignancies and the second most commonly diagnosed gynecologic malignancy.

Most women don't know they have ovarian cancer until it's too late.

Some researchers suggested that TCGA's ovarian cancer project has been disappointing because it didn't find any novel cancer genes and most genes it did find are rare.

She translates the most promising immunotherapy strategies for breast cancer to the clinic, and is now extending these strategies to ovarian cancer.

In their most intriguing work, they're collaborating on something new: a «theranostic» nanoparticle that can both diagnose and attack ovarian tumors.

The earliest and one of the most striking came from observations that the presence of infiltrating T cells (called «tumor - infiltrating lymphocytes,» or TILs) in ovarian tumors is positively and strongly associated with improved survival of patients with ovarian cancer [1].

Most of these therapies are still in early - phase testing (phase I and II) for ovarian cancer, but their successful use in other types of cancers suggests that they may ultimately prove useful for ovarian cancer as well.